Physician profile
Michael Gehring
NPI 1487117511
$2,441.44
in general payments reported to CMS, 2019-2025
12 companies · $1,403 in 2025
The $1,403 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $546 · 2024: $492 · 2025: $1,403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $863 · Food and Beverage: $832 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $863.26 |
| Food and Beverage | $832.02 |
| Education | $199.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $1,118.26 | 2025 | |
| Medical Device Business Services, INC. | $211.99 | 2024 | Mentor Memorygel Breast Implant, Mentor Memorygel Resterilizable Gel Sizer, Trumatch |
| Stryker Corporation | $171.56 | 2022 | |
| Endo USA, INC. | $146.20 | 2025 | Xiaflex |
| Allergan, INC. | $129.34 | 2022 | |
| Sonex Health, INC. | $125.77 | 2022 | |
| Innovation Technologies INC | $119.50 | 2022 | |
| Polynovo North America LLC | $104.05 | 2024 | Novosorb Btm |
| Depuy Synthes Sales INC. | $101.30 | 2024 | Matrixmandible |
| Motiva USA, LLC | $90.47 | 2025 | |
| Abbvie INC. | $74.75 | 2024 | |
| Mentor Worldwide LLC | $48.25 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gehring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.